Aaron Berez

Aaron is an international thought leader in interventional radiology, with a career in medicine, innovation and commercialization. He currently leads Alembic, LLC, a medical device company in Mountain View, CA, which develops novel medical devices. He is a board member of numerous medtech companies in the US and Canada. Aaron was VP of Clinical Affairs at Smart Therapeutics, Inc., before co-founding Chestnut Medical Technologies, Inc. where as CEO he led the development of innovative devices for Interventional Neuroradiology, including the Pipeline Embolization Device© (PED), which was acquired by eV3 Inc. in June 2009. Aaron completed post-graduate training at Stanford University in Radiology and Neuroradiology.